Avanir Pharmaceuticals, Inc.

CIK 858803 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Avanir Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Apr 28, 2015ARS9999999997-15-009381
Feb 11, 2015SC 13G/A0001519058-15-000043
Feb 10, 2015SC 13G/A0000080255-15-000044
Feb 9, 2015SC 13G/A0000080255-15-000018
Jan 26, 2015SC 13G/A0001086364-15-000849
Jan 15, 201515-12B0001193125-15-011873
Jan 14, 2015EFFECT9999999995-15-000095
Jan 14, 2015EFFECT9999999995-15-000096
Jan 13, 2015S-8 POS0001193125-15-009070
Jan 13, 2015S-8 POS0001193125-15-009042
Jan 13, 2015S-8 POS0001193125-15-009034
Jan 13, 2015S-8 POS0001193125-15-009049
Jan 13, 2015POS AM0001193125-15-009081
Jan 13, 2015S-8 POS0001193125-15-009077
Jan 13, 2015S-8 POS0001193125-15-009071
Jan 13, 2015S-8 POS0001193125-15-009037
Jan 13, 2015S-8 POS0001193125-15-009055
Jan 13, 20158-K0001193125-15-008886
Jan 13, 2015SC TO-T/A0001193125-15-008807
Jan 13, 2015S-8 POS0001193125-15-009032
Jan 13, 2015POS AM0001193125-15-009079
Jan 13, 2015S-8 POS0001193125-15-009059
Jan 13, 201525-NSE0001354457-15-000005
Jan 13, 2015S-8 POS0001193125-15-009066
Jan 13, 2015S-8 POS0001193125-15-009051